Cerebral Embolic Protection Devices (CEPDs) During Transcatheter Aortic Valve Implantation (TAVI): A Meta-Analysis of Randomized Controlled Trials
Bibliographic Information Authors: Gbreel M.I.; Badran A.S.; Hassan M.; Balata M. Journal: Clinical Cardiology Publisher: John Wiley and Sons Inc Publication Date: 23 April 2026 Volume / Issue: Volume 49 / Issue 4 Article No.: e70309 ISSN: 1609289 DOI: 10.1002/clc.70309 Scopus: View on Scopus PubMed: 42021683 Document Type: Review Access: All Open Access; Gold Open Access; Green Open Access Authors and Affiliations Gbreel M.I., Faculty of Medicine, October 6 University, Giza, Egypt; Badran A.S., Faculty of Medicine, Ain Shams University, Cairo, Egypt; Hassan M., Theodor Bilharz Research Institute, Giza, Egypt; Balata M., Department of Cardiology, University Hospital Rostock, Rostock, Germany Abstract Aims: Transcatheter aortic valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection devices (CEPDs) are designed to reduce the risk of embolic debris reaching the brain; however, the evidence supporting their efficac...